Selection and delineation of target volumes in head and neck tumors: Beyond ICRU definition;Sélection et délimitation des volumes cibles dans la sphère cervico-maxillo-faciale: Au-delà des concepts de l'ICRU

Cancer/Radiotherapie

Volumn 6, Issue SUPPL. 1, 2002, Pages

  Gregoire V ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Gross tumor volume; Intensity modulated radiation therapy; Positron emission tomography; Spectroscopic magnetic resonance imaging

Indexed keywords

CANCER RADIOTHERAPY; CELL PROLIFERATION; CONFERENCE PAPER; HEAD AND NECK CANCER; HUMAN; HYPOXIA; IONIZING RADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION;

HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 17344375931     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Anderson H, Price P. What does positron emission tomography offer oncology? Eur J Cancer 2000;36:2028-35.
2. Borbath I, Gregoire V, Bergstrom M, Laryea D, Langstrom B, Pauwels S. Use of 5-[76 Br] bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: Validation in an animal tumour model. Eur J Nuclear Med Mol Imaging 2002;29:19-27.
3. Braun RD, Lanzen JL, Dewhirst MW. Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Am J Physiol 1999;277(2 Pt 2):H551-68.
4. Bussink J, Kaanders JH, Rijken PF, Martindale CA, van der Kogel AJ. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br J Cancer 1998;77(1):57-64.
5. Bussink J, Kaanders JH, Rijken PF, Raleigh JA, van der Kogel AJ. Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiat Res 2000;153(4):398-404.
6. Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiar Oncol Biol Phys 2001;49(4):1171-82.
7. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am. 2001;39:883-917.
8. Goda F, O'Hara JA, Rhodes ES, Liu KJ, Dunn JF, Bacic G, et al. Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation. Cancer Res 1995;55(11):2249-52.
9. Gross MW, Weber WA, Feldmann HJ, Bartenstein P, Schwaiger M, Molls M. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. Int J Radiat Oncol Biol Phys 1998;41:989-95.
10. Grosu AL, Weber W, Feldmann HJ, Wuttke B, Bartenstein P, Gross MW, et al. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys 2000;47:517-26.
11. Haustermans K, Vanuytsel L, Geboes K, Lerut T, Van Thillo J, Leysen J, et al. In vivo cell kinetic measurements in human oesophageal cancer: What can be learned from multiple biopsies? Eur J Cancer 1994;30A(12):1787-91.
12. Humm JL, Lee JB, O'Donoghue JA, Squire O, Ling CC, Pentlow K, et al. Changes in FDG tumor uptake during and after radiation therapy in a rodent tumor xenograft. J Clin PET 1999;2:289-96.
13. 18F]-labelled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia. Bioorg Med Chem 2001;9:665-75.
14. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47(3):551-60.
15. Pickett B, Vigneault E, Kurhanewicz J, Verhey L, Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 1999;44(4):921-9.
16. Trott KR, Kummermehr J. Rapid repopulation in radiotherapy: A debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 1991;22(3):159-60.
17. Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, et al. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000;55:317-24.